Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Creosote is a complex mixture of phenols and polycyclic aromatic hydrocarbons (PAHs) derived from the distillation of coal tar or wood tar (such as beechwood). In clinical practice, wood-tar creosote is primarily used as a dental antiseptic and disinfectant, particularly in root canal treatments for primary teeth with periapical periodontitis. It acts through non-specific antimicrobial mechanisms, including protein denaturation. Beyond its medicinal use, coal-tar creosote is a major industrial wood preservative for railroad ties and utility poles, though its use is increasingly regulated due to the presence of carcinogenic PAHs and environmental persistence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on creosote.